Back to results
US 2019/0194182 A1Published application
Rad51 inhibitors
AssigneeCyteir Therapeutics, Inc.
InventorsAlfredo C. CASTRO, Casey Cameron MCCOMAS, Joseph VACCA, Tyler MACLAY
Life of this patent
Estimating the term…
Abstract
This application is directed to inhibitors of RAD51 represented by the following structural formula, and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
Claims18
A compound of the following structure:
- or a pharmaceutically acceptable salt thereof.
A compound of the following structure:
Dependencies are inferred from the claim text.